Catalyst Event

Boston Scientific Corp (BSX) · Other

From Akros U.S. Tech 100 Protective Allocation Monthly Index (A100PAM)

4/26/2026, 12:00:00 AM

OtherSentiment: Positive

Presentation of positive clinical trial data for FARAPULSE and WATCHMAN devices at the Heart Rhythm 2026 conference on 2026-04-26. This event is estimated to have a 1-5% price impact, scheduled.

Korean Translation

2026년 4월 26일 Heart Rhythm 2026 컨퍼런스에서 FARAPULSE 및 WATCHMAN 기기 임상 데이터 발표 예정임. 해당 발표는 1-5% 수준의 주가 영향이 예상됨.

Related Recent Events

View Full Timeline